Examining Influenza Vaccination Patterns Among Young Adults with Asthma: Insights into Knowledge, Attitudes, and Practices.
asthma
exacerbation
influenza
influenza vaccine
morbidity
Journal
Patient preference and adherence
ISSN: 1177-889X
Titre abrégé: Patient Prefer Adherence
Pays: New Zealand
ID NLM: 101475748
Informations de publication
Date de publication:
2023
2023
Historique:
received:
14
09
2023
accepted:
04
11
2023
medline:
29
11
2023
pubmed:
29
11
2023
entrez:
29
11
2023
Statut:
epublish
Résumé
Asthma is a major chronic disease of all ages, globally. Exacerbations are a significant problem for asthmatic patients. Despite advances in asthma management and efforts to identify asthma triggers, viral infections of the respiratory tract remain the most frequent triggers of asthma exacerbations. This study explored knowledge, attitudes, and practices (KAP) of asthmatic patients towards receiving the influenza vaccine. This cross-sectional study enrolled 397 adult asthmatic patients visiting the outpatient respiratory clinics of three Jordanian medical facilities. The research included 66.4% females, with a median age of 32 years. The results showed that 42.4% of enrolled asthmatics had never received the flu vaccine and only 51.1% reported that they intended to take the vaccine in the current year. Most of those who had been vaccinated at least once in their lifetime reported that the side effects were mild (61.8%). Variables that decreased refusal/hesitancy towards receiving the flu vaccine in the current year included having well-controlled asthma (RRR = 0.193, 95% Cl (0.053-0.698), p =0.012), and high knowledge about asthma and flu (RRR= 0.916, 95% Cl (0.847-0.990), p =0.028, respectively). A small number of the participants adhered to vaccinating against the flu which is due to lack of knowledge about the asthma, flu, and the vaccine. To address this challenge, we propose targeted health education campaigns, collaboration with healthcare providers, and utilization of digital platforms.
Identifiants
pubmed: 38027079
doi: 10.2147/PPA.S436622
pii: 436622
pmc: PMC10644889
doi:
Types de publication
Journal Article
Langues
eng
Pagination
2899-2913Informations de copyright
© 2023 Al-Qerem et al.
Déclaration de conflit d'intérêts
The authors report no conflicts of interest in this work.
Références
BMC Public Health. 2011 Jan 06;11(1):15
pubmed: 21211000
Clin Infect Dis. 2017 Oct 15;65(8):1388-1395
pubmed: 28591866
Eur Respir J. 2019 Oct 24;54(4):
pubmed: 31649149
Vaccines (Basel). 2023 Jun 07;11(6):
pubmed: 37376462
J Community Health. 2018 Apr;43(2):297-303
pubmed: 28852915
Br J Gen Pract. 2007 May;57(538):359-63
pubmed: 17504585
Prev Med. 1999 Oct;29(4):249-62
pubmed: 10547050
NPJ Digit Med. 2021 Sep 17;4(1):138
pubmed: 34535755
Biol Sex Differ. 2020 May 4;11(1):24
pubmed: 32366281
Public Health Rep. 2023 Jan-Feb;138(1):85-90
pubmed: 35060785
BMJ. 2021 Sep 30;374:n2061
pubmed: 34593508
Cureus. 2019 Dec 25;11(12):e6460
pubmed: 32021734
Implement Sci. 2011 Apr 23;6:42
pubmed: 21513547
Can J Infect Dis Med Microbiol. 2020 Oct 16;2020:7653745
pubmed: 33123302
Vaccines (Basel). 2021 Oct 15;9(10):
pubmed: 34696294
Vaccine. 2010 Sep 7;28(39):6470-7
pubmed: 20674882
Hum Vaccin Immunother. 2022 Nov 30;18(5):2044257
pubmed: 35240943
Public Health Rep. 2006 Mar-Apr;121(2):181-8
pubmed: 16528952
Lancet Reg Health Am. 2023 May 30;23:100526
pubmed: 37293392
J Pediatr Health Care. 2013 Sep-Oct;27(5):327-33
pubmed: 22321581
Front Public Health. 2022 Oct 13;10:950532
pubmed: 36330121
Health Promot Int. 2015 Sep;30(3):736-45
pubmed: 23985248
Int J Pharm Pract. 2022 Jan 7;30(1):5-16
pubmed: 34791260
PLoS One. 2017 Jan 26;12(1):e0170550
pubmed: 28125629
J Asthma Allergy. 2020 Oct 29;13:545-555
pubmed: 33149626